Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study

Title
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study
Authors
Keywords
Antiandrogen, Bicalutamide, Localised, Locally advanced, Prostate cancer, Survival
Journal
EUROPEAN JOURNAL OF CANCER
Volume 51, Issue 10, Pages 1283-1292
Publisher
Elsevier BV
Online
2015-04-17
DOI
10.1016/j.ejca.2015.03.021

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now